Elanco Animal Health Incorporated reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 1,177 million compared to USD 1,279 million a year ago. Net loss was USD 22 million compared to USD 210 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.43 a year ago. Diluted loss per share from continuing operations was USD 0.04 compared to USD 0.43 a year ago.
For the six months, sales was USD 2,402 million compared to USD 2,521 million a year ago. Net income was USD 26 million compared to net loss of USD 271 million a year ago. Basic earnings per share from continuing operations was USD 0.05 compared to basic loss per share from continuing operations of USD 0.56 a year ago. Diluted earnings per share from continuing operations was USD 0.05 compared to diluted loss per share from continuing operations of USD 0.56 a year ago.